Open Label Pilot Study of the Effects of Memantine on FDG-PET in Frontotemporal Dementia
This study has been completed.
Tiffany Chow, MD
H. Lundbeck A/S
Information provided by (Responsible Party):
Tiffany Chow, MD, Rotman Research Institute at Baycrest
First received: January 7, 2008
Last updated: June 1, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||June 2012|
|Primary Completion Date:||June 2012 (Final data collection date for primary outcome measure)|
Chow TW, Binns MA, Freedman M, Pollock BG, Verhoeff NPG, Graff-Guerrero A. Pre- and post-memantine FDG-PET imaging in frontotemporal dementia. Am J Geriatr Psychiatry 2009;17(3 Supp 1): A73.
Chow TW, Fam D, Graff-Guerrero A, Binns MA, Verhoeff NPG, Tang-Wai D, Masellis M, Black SE, Wilson AA, Houle S, Pollock BG. Fluorodeoxyglucose positron emission tomography in semantic dementia after 6 months of memantine: an open-label pilot study. International Journal of Geriatric Psychiatry 2012 [in press].